Lucatumumab (HCD122) is a fully human anti-CD40 monoclonal antibody with antitumor activity that blocks the interaction of CD40L with CD40 and inhibits the CD40/CD40L-mediated signaling pathway for the study of chronic lymphocytic leukemia (CLL) and multiple myeloma.
Purity:
95.00%
CAS Number:
[903512-50-5]
Target:
TNF
* VAT and and shipping costs not included. Errors and price changes excepted